Senzime AB
Explore this company’s associated devices, FDA decisions and regulatory history.

Senzime AB
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Senzime AB. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 22, 2026 to May 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code KOI appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Verkstadsgatan 8, Uppsala, 75323, SE. Recorded on K261098, decision dated May 22, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
TetraGraph Neuromuscular Transmission Monitor (SEN 2015)Accessories:TetraSens (SEN 2012)TetraSens Pediatric (SEN 2013)TetraSensitive (SEN 2016)TetraHub (SEN 2017)
K261098 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.